9 Results for "

GluN1/GluN2A

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "GluN1/GluN2A" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13457
CAS No.: 852918-02-6
Purity:  99.06%
Target:  

iGluR

Research Areas:  

Neurological Disease

TCN 201 is a potent, selective and non-competitive antagonist of GluN1/GluN2A NMDA receptor, with a pIC50 of 6.8. TCN 201 is selective for GluN1/GluN2A NMDA receptor over GluN1/GluN2B NMDA receptor (pIC50<4.3) [1] [2].
loading...
    loading...
Cat. No.: HY-124569
CAS No.: 1237541-73-9
Purity:  98.26%
Target:  

iGluR

Research Areas:  

Neurological Disease

NAB-14 is a potent, selective, orally active and non-competitive GluN2C/2D antagonists with an IC50 of 580 nM for GluN1/GluN2D. NAB-14 shows >800-fold selective for recombinant GluN2C and GluN2D over GluN2A and GluN2B. NAB-14 can cross the blood-brain-barrier [1].
loading...
    loading...
Cat. No.: HY-178121
CAS No.: 3106013-91-3
Target:  

iGluR

JNJ-78911118 is a potent, brain-penetrant, selective GluN2A antagonist (IC50 = 44 nM). JNJ-78911118 shows >200-fold selectivity against GluN1/2B, 2C and 2D receptors. JNJ-78911118 functions as a negative allosteric modulator (NAM) by insurmountably suppressing glutamate efficacy and reducing glycine potency at GluN1/2A receptors. JNJ-78911118 produces profound pharmacodynamic effects in vivo. JNJ-78911118 can be used for depression research [1].
loading...
    loading...
Cat. No.: HY-117734
CAS No.: 1560894-05-4
Purity:  98.13%
Target:  

iGluR

Research Areas:  

Neurological Disease

PYD-106 is a stereoselective pyrrolidinone (PYD) positive allosteric modulator for GluN2C-containing NMDA receptors. PYD-106 increases opening frequency and open time of single channel currents activated by maximally effective concentrations of agonist but only has modest effects on glutamate and glycine EC50. PYD-106 selectively enhances the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors [1].
loading...
    loading...
Cat. No.: HY-107712
CAS No.: 556803-08-8
Purity:  99.16%
Target:  

iGluR

Research Areas:  

Neurological Disease

TCN 213 is a selective, surmountable, glycine-dependentlly GluN1/GluN2A NMDAR antagonist with IC50s of 0.55, 3.5, 40 μM in the presence of 75, 750, 7500 nM glycine, respectively. TCN 213 can be used to monitor, pharmacologically, the switch in NMDAR expression in developing cortical neurones [1] [2].
loading...
    loading...
Cat. No.: HY-100839
CAS No.: 138199-51-6
Purity:  96.53%
Synonyms: D,L-(tetrazol-5-yl)glycine; LY 285265
Target:  

iGluR

Research Areas:  

Neurological Disease

(RS)-(Tetrazol-5-yl)glycine (D,L-(tetrazol-5-yl)glycine) is a highly potent and selective N-methyl-D-aspartate (NMDA) receptor agonist [1]. (RS)-(Tetrazol-5-yl)glycine has EC50s of 99 nM, 1.7 μM for GluN1/GluN2D and GluN1/GluN2A, respectively [2]. (RS)-(Tetrazol-5-yl)glycine induces seizure responses and Fos in mice .
loading...
    loading...
Cat. No.: HY-120523
CAS No.: 1333213-35-6
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP646 is a potent GluN1/GluN2D receptors potentiator, and also potentiates the other three subtypes, GluN1/GluN2A, GluN1/GluN2B, and GluN1/GluN2C receptors [1].
loading...
    loading...
Cat. No.: HY-172213
CAS No.: 1585965-04-3
Target:  

iGluR

Research Areas:  

Neurological Disease

(3S,6R)-NML is a NMDA receptor antagonist, with pIC50s of 4.8 (GluN1-GluN2A), 4.6 (GluN1-GluN2B), 5.0 (GluN1-GluN2C), 5.0 (GluN1-GluN2D) respectively. (3S,6R)-NML can be used for depression research [1].
loading...
    loading...
Cat. No.: HY-179573
CAS No.: 1210899-51-6
Target:  

iGluR

Research Areas:  

Neurological Disease

UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors with EC50 values of 21 µM and 19 µM at GluN1/GluN3A and GluN1/GluN3B receptors, respectively. UCM-A86 selectively potentiates responses from GluN1/GluN3A/B over GluN1/GluN2A-D receptors. UCM-A86 can be used in the research of central nervous system diseases [1].
loading...
    loading...